Comparison of the Physical Activity in Cancer Patients Assessed by Questionnaire and Motion Tracker
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: No intervention - observational study only.
- Who it may be relevant to
- Registry conditions: Lymphoma, Pancreas Cancer, Colorectal Cancer. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Germany
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Comparison of the Physical Activity Assessed by an Accelerometer and the International Physical Activity Questionnaire in Oncologic Patients
Overview
Physical activity is an important aspect of cancer therapy but correct measurement of physical activity is difficult. In this study, the physical activity of patients undergoing cancer therapy is assessed by questionnaire and by motion tracker. The results are then compared to answer whether there are differences between the two measurements. Findings of this study will help to improve the assessment of physical activity in cancer patients.
Detailed description
Although physical activity has been identified as a relevant determinant of cancer therapy outcome, its valid assessment remains challenging. In principle, direct and indirect assessment instruments can be employed for assessment of physical activity. While direct instruments, e.g. accelerometers, are considered to provide a more objective measurement, indirect tools such as questionnaires are less expensive and more applicable for use in larger study populations. The validity of both forms of measurements in cancer patients is however not well studied. Therefore, this study aims to elucidate the relative validity of an accelerometer in comparison to a standardized physical questionnaire at different time points of cancer therapy. Findings of this study will allow conclusions regarding the ideal modalities for assessment of physical activity in cancer patients.
Interventions
- Other No intervention - observational study only
No intervention - observational study only
Primary outcome measures
- Comparison of physical activity assessments within 1 week after initiation of cancer therapy [Time frame: 1 week after initiation of cancer therapy]
Secondary outcome measures (12)
- Comparison of physical activity assessments 12 weeks after initiation of cancer therapy [Time frame: 12 weeks after initiation of cancer therapy]
- Comparison of changes in physical activity between assessements within 1 week and 12 weeks after initiation of cancer therapy [Time frame: 12 weeks after initiation of cancer therapy]
- Physical activity assessed by accelerometer [Time frame: 1 week after initiation of cancer therapy, 12 weeks after initiation of cancer therapy]
- Physical activity assessed by questionnaire [Time frame: 1 week before initiation of cancer therapy, 1 week after initiation of cancer therapy, 12 weeks after initiation of cancer therapy]
- Relation of Eastern Co-operative Oncology Group (ECOG) Performance Status to physical activity assessed by accelerometer [Time frame: 1 week after initiation of cancer therapy, 12 weeks after initiation of cancer therapy]
- Relation of Eastern Co-operative Oncology Group (ECOG) Performance Status to physical activity assessed by questionnaire [Time frame: 1 week before initiation of cancer therapy, 1 week after initiation of cancer therapy, 12 weeks after initiation of cancer therapy]
- Relation of Karnofsky Performance Status (KPS) to physical activity assessed by accelerometer [Time frame: 1 week after initiation of cancer therapy, 12 weeks after initiation of cancer therapy]
- Relation of Karnofsky Performance Status (KPS) to physical activity assessed by questionnaire [Time frame: 1 week before initiation of cancer therapy, 1 week after initiation of cancer therapy, 12 weeks after initiation of cancer therapy]
- Relation of age to physical activity assessed by accelerometer [Time frame: 1 week after initiation of cancer therapy]
- Relation of age to physical activity assessed by questionnaire [Time frame: 1 week after initiation of cancer therapy]
- Relation of sex to physical activity assessed by accelerometer [Time frame: 1 week after initiation of cancer therapy]
- Relation of sex to physical activity assessed by questionnaire [Time frame: 1 week after initiation of cancer therapy]
Eligibility criteria
Inclusion criteria
- verified diagnosis of lymphoma, colorectal or pancreatic cancer
- requirement of surgical, chemo or radio therapy
- provision of informed consent
Exclusion criteria
- pregnancy
- inability to provide consent
- use of a rollator
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Other
Study locations
Germany · 1 center
- University Medicine Greifswald — Greifswald
Identifiers
NCT: NCT05501379 · BB 067/22